Michelle Dawson posts

Post published on Twitter/X on 27 Jan 2021 11:20

Back to posts Previous post Next post
Twitter/X Clinical trial clinicaltrials.gov Extract quoted in the post Question asked by Dawson in the post External link integrated into the post Autism terms
Open original post

Information about the link integrated into the post

Clinical trial

University of Missouri, Kansas City (2023). Amitriptyline for Repetitive Behaviors in Autism Spectrum Disorders. ClinicalTrials.gov. University of Missouri, Kansas City.

More information

Structured cited links

1 cited resource

Clinical trial Fetched Post clinicaltrials.gov

University of Missouri, Kansas City (2023). Amitriptyline for Repetitive Behaviors in Autism Spectrum Disorders. ClinicalTrials.gov. University of Missouri, Kansas City.

Publication date
1 Nov 2023
Identifier
NCT04725383
Authors
University of Missouri, Kansas City
Source
ClinicalTrials.gov
Reference type
clinical_trial
Publisher
University of Missouri, Kansas City
Metadata source
clinicaltrials.gov

Abstract

The investigators will recruit 30 children and adolescents (15 per group x 2 groups) aged 6 to 17 years with ASD and significant repetitive behaviors that cause problems to them and to others around them. Subjects will be randomized to either amitriptyline (AMI), dosed flexibly according to response and tolerability with a maximum dose of 100mg per day or 1.5mg/kg/day, in divided doses to minimize side effects, or placebo in look-alike capsules, for 10 weeks. Rating scales will be used to measure outcomes.

Open source